Pathology Laboratory Testing at the Crossroads: Will Payers Deeply Discount Prices for Genetic Tests, or Will Value-Based Pricing Prevail?

Big changes in how these lab test claims are handled are just 11 weeks away, and most clinical laboratories are not up to speed on this issue Note: Dark Daily offers this opinion and commentary by Editor Robert L. Michel Big changes are coming in how payers handle code stacked claims for genetic tests and molecular diagnostic assays! However, few pathologists and clinical laboratory administrators understand why the collective efforts of payers to control utilization and reimbursement of these...
;